Key Financial Data Of Reporting Company

Oncolys BioPharma Inc. - Filing #7712920

Concept As at
2018-12-31
2018-01-01 to
2018-12-31
As at
2017-12-31
2017-01-01 to
2017-12-31
As at
2016-12-31
2016-01-01 to
2016-12-31
As at
2015-12-31
2015-01-01 to
2015-12-31
As at
2014-12-31
2014-01-01 to
2014-12-31
Key financial data of reporting company
Business results of reporting company
Net sales
168,549,000 JPY
229,139,000 JPY
178,313,000 JPY
121,303,000 JPY
28,797,000 JPY
Ordinary profit (loss)
-1,230,105,000 JPY
-1,087,185,000 JPY
-864,241,000 JPY
-854,701,000 JPY
-726,082,000 JPY
Profit (loss)
-1,233,846,000 JPY
-1,090,703,000 JPY
-931,397,000 JPY
-857,290,000 JPY
-738,999,000 JPY
Equity in earnings (losses) of affiliates if equity method is applied
JPY
JPY
JPY
JPY
JPY
Share capital
6,402,658,000 JPY
5,802,444,000 JPY
5,090,981,000 JPY
5,072,338,000 JPY
5,072,278,000 JPY
Total number of issued shares
13,346,000 xbrli:shares
11,086,000 xbrli:shares
9,234,600 xbrli:shares
9,183,800 xbrli:shares
9,183,200 xbrli:shares
Net assets
2,901,153,000 JPY
2,931,893,000 JPY
2,617,383,000 JPY
3,501,470,000 JPY
4,371,484,000 JPY
Total assets
3,430,112,000 JPY
3,526,222,000 JPY
3,140,313,000 JPY
4,005,959,000 JPY
5,008,761,000 JPY
Net assets per share
216.61
263.54
283.43
381.27
476.03
Dividend paid per share
Interim dividend paid per share
Basic earnings (loss) per share
-104.55
-106.23
-101.18
-93.35
-80.55
Diluted earnings per share
Equity-to-asset ratio
0.8430 xbrli:pure
0.829 xbrli:pure
0.827 xbrli:pure
0.872 xbrli:pure
0.872 xbrli:pure
Rate of return on equity
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Price-earnings ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Payout ratio
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
xbrli:pure
Net cash provided by (used in) operating activities
-1,187,579,000 JPY
-1,096,840,000 JPY
-903,424,000 JPY
-755,756,000 JPY
-814,489,000 JPY
Net cash provided by (used in) investing activities
342,040,000 JPY
131,662,000 JPY
256,627,000 JPY
1,754,808,000 JPY
-3,408,702,000 JPY
Net cash provided by (used in) financing activities
1,147,270,000 JPY
1,476,503,000 JPY
6,423,000 JPY
-120,060,000 JPY
-233,000 JPY
Cash and cash equivalents
2,218,074,000 JPY
1,922,454,000 JPY
1,418,993,000 JPY
2,060,252,000 JPY
1,182,466,000 JPY
Number of employees
30 xbrli:pure
29 xbrli:pure
30 xbrli:pure
29 xbrli:pure
28 xbrli:pure
Average number of temporary employees
6 xbrli:pure
6 xbrli:pure
6 xbrli:pure
7 xbrli:pure
7 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.